Consensus statement on severe asthma amid COVID-19

New Clinical Recommendations For COVID-19 In Severe Asthma emphasise the importance of maintaining usual asthma therapy including monoclonal antibodies and oral corticosteroids when indicated. The consensus document, from the Centre of Excellence in Severe Asthma in Newcastle, said there was no evidence to suggest that asthma or MAB therapy constituted an increased risk for acquiring ...

Already a member?

Login to keep reading.

© 2022 the limbic